Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  sphingosine kinase-2 inhibitor ABC294640
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
Sphingosine Kinase-2 Inhibitor ABC294640 in Treating Patients with Advanced Liver Cancer Who Have Progressed on Sorafenib Tosylate
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 102418, NCI-2016-01585, NCT02939807
Start Over